Dr. Stephanie McCabe is a science advisor in in the firm’s Business Law Department and a member of its Intellectual Property group. She joined Goodwin in 2018.





Her practice focuses on intellectual property matters in the life science industry with a focus on chemical therapeutics. She assists clients with prior art research, patent preparation, patent prosecution, and freedom to operate analyses. She has extensive experience in the fields of synthetic organic chemistry, natural product total synthesis, and pharmaceuticals.

Professional Experience

Prior to joining Goodwin, Dr. McCabe conducted doctoral research directed toward synthetic method development and natural product total synthesis. As a graduate student, she carried out an enantioselective total synthesis of the ergot alkaloid cycloclavine, investigated a new amine protecting group, and developed a novel Rh(II)-catalyzed asymmetric cyclopropanation. She has presented her work at invited lectures and national conferences, and authored scientific articles in peer-reviewed journals including Angewandte Chemie International Edition and Organic and Biomolecular Chemistry.

Professional Activities

Member of the American Chemical Society.


During her time in graduate school, she was the recipient of several fellowships and awards including the Andrew Mellon Fellowship and Genentech Graduate Student Award in Chemical Research.






Ph.D., Organic Chemistry, 2018
University of Pittsburgh
B.Sc., Organic Chemistry, 2012
The Australian National University
(First Class Honors)
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique